SplitJun 26, 2026, 09:06 AM
HCW Biologics Announces 1-for-6 Reverse Stock Split Effective June 30
AI Summary
HCW Biologics Inc. announced a 1-for-6 reverse stock split, effective June 30, 2026, to maintain compliance with Nasdaq's $1.00 minimum bid price requirement. The Board of Directors approved the split after stockholders granted the authority, aiming to prevent automatic delisting. The reverse split will reduce the number of outstanding shares and adjust options and warrants proportionately, with fractional shares rounded up.
Key Highlights
- Board approved a 1-for-6 reverse stock split.
- Effective date for the reverse split is June 30, 2026, at 12:01 a.m. Eastern time.
- Purpose is to ensure compliance with Nasdaq's $1.00 Bid Price Rule and Panel requirements.
- Outstanding shares will reduce from 9,581,079 to approximately 1,596,849.
- Fractional shares will be rounded up to the next whole share.
- Options and warrants will be adjusted by dividing shares by six and multiplying exercise price by six.
- New CUSIP number for the Common Stock will be 40423R303.
Price Impact
More from HCWB